Impact of an Infusion Therapy Nursing Expert Service on Length of Stay and Clinical Results of Venous Access Devices (ETI)
|ClinicalTrials.gov Identifier: NCT01548365|
Recruitment Status : Completed
First Posted : March 8, 2012
Last Update Posted : September 23, 2013
|Condition or disease||Intervention/treatment|
|Patients With Prolonged Intravenous Therapy||Other: Infusion therapy nursing expert service|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||82 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Health Services Research|
|Official Title:||Impact of an Infusion Therapy Nursing Expert Service on Length of Stay, Clinical Results of Venous Access Devices and Satisfaction on Patients With Long Intravenous Therapy Prescription.|
|Study Start Date :||March 2012|
|Primary Completion Date :||September 2012|
|Study Completion Date :||December 2012|
No Intervention: Control Group
routine care for the selection, placement and maintenance of venous access devices (VAD).
Experimental: Infusion Therapy Nursing Expert
Patients in this group will receive the infusion therapy nursing expert (ITNE) service.
Other: Infusion therapy nursing expert service
The ITNE will assess the patient and treatment characteristics and use an evidence based decision making algorithm for the selection of the most suitable VAD.
If the VAD needed is a PICC or a midline ITNE will place it following hospital's protocols. If needed, ITNE will also educate and support patients and next of keens in the maintenance of the device at home.
If other devices such as peripheral catheters, central venous catheters (jugular or subclavian) or venous subcutaneous reservoirs are the preferable VADs for patients and treatment conditions, ITNE will work together with health professionals in charge of patients to activate the usual procedures to place the according device.
- Hospital Length of Stay [ Time Frame: 3 months ]
- Venous Access Devices reaching end of treatment [ Time Frame: 3 months ]
- Incidence of complications derived from VAD [ Time Frame: 3 months ]
- Patients receiving intravenous therapy at home [ Time Frame: 3 months ]
- Patient satisfaction with VAD [ Time Frame: 3 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01548365
|Araba University Hospital|
|Vitoria-Gasteiz, Araba, Spain, 01009|
|Principal Investigator:||Lucia Garate, MsC||Basque Health Service|